Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation positive advanced non-small cell lung cancer (Oscillate)

被引：0
|
作者：
Mersiades, Antony [1 ]
Pavlakis, Nick [2 ]
Kao, Steven [3 ]
John, Tom [4 ]
Lee, Chee Khoon [1 ,5 ]
Dawson, Sarah-Jane [6 ]
Wong, Stephen [6 ]
Tan, Lavinia [6 ]
Yip, Sonia [1 ]
Brown, Chris [1 ]
Livingstone, Ann [1 ]
Cheung, Yvonne [1 ]
Jurkovic, Hannora [1 ]
Stockler, Martin [1 ]
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[2] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[3] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[4] Olivia Newton John Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[5] St George Hosp, Dept Med Oncol, Sydney, NSW, Australia
[6] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [21] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
    Akamatsu, Hiroaki
    Katakami, Nobuyuki
    Okamoto, Isamu
    Kato, Terufumi
    Kim, Young Hak
    Imamura, Fumio
    Shinkai, Masaharu
    Hodge, Rachel A.
    Uchida, Hirohiko
    Hida, Toyoaki
    [J]. CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
  • [22] Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
    Ahn, Myung-Ju
    Han, Ji-Youn
    Kim, Dong-Wan
    Cho, Byoung Chul
    Kang, Jin-Hyoung
    Kim, Sang-We
    Yang, James Chih-Hsin
    Mitsudomi, Tetsuya
    Lee, Jong Seok
    [J]. CANCER RESEARCH AND TREATMENT, 2020, 52 (01): : 284 - 291
  • [23] Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
    Lee, J. C.
    Yang, S.
    Oh, D. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S806 - S807
  • [24] The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib
    Buder, Anna
    Hochmair, Maximilian J.
    Filipits, Martin
    [J]. TARGETED ONCOLOGY, 2021, 16 (01) : 77 - 84
  • [25] Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data
    Ahn, M-J
    Lee, J-S.
    Han, J-Y.
    Kim, D-W.
    Cho, B. C.
    Kang, J. H.
    Kim, S-W.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [26] The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib
    Anna Buder
    Maximilian J. Hochmair
    Martin Filipits
    [J]. Targeted Oncology, 2021, 16 : 77 - 84
  • [27] Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
    Auliac, Jean Bernard
    Perol, Maurice
    Planchard, David
    Monnet, Isabelle
    Wislez, Marie
    Doubre, Helene
    Guisier, Florian
    Pichon, Eric
    Greillier, Laurent
    Mastroianni, Benedicte
    Decroisette, Chantal
    Schott, Roland
    Le Moulec, Sylvestre
    Arrondeau, Jennifer
    Cortot, Alexis B.
    Geriniere, Laurence
    Renault, Aldo
    Daniel, Catherine
    Falchero, Lionel
    Chouaid, Christos
    [J]. LUNG CANCER, 2019, 127 : 96 - 102
  • [28] Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
    Wang, Rou-Hsin
    Chang, Chien-Jen
    Chen, Chien-Hung
    Liu, Kuang-Kai
    Chao, Jui-, I
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (11) : 1309 - 1319
  • [29] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
  • [30] Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)
    Eide, Inger Johanne Zwicky
    Helland, Aslaug
    Ekman, Simon
    Mellemgaard, Anders
    Hansen, Karin Holmskov
    Cicenas, Saulius
    Koivunen, Jussi
    Gronberg, Bjorn Henning
    Brustugun, Odd Terje
    [J]. LUNG CANCER, 2020, 143 : 27 - 35
12345